Detroit, MI, United States of America

Dennis J Goebel

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Detroit, MI (US) (2016 - 2018)
  • Wixom, MI (US) (2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dennis J Goebel

Introduction

Dennis J Goebel is a notable inventor based in Detroit, MI (US), recognized for his significant contributions to the field of neuroprotection. With a total of 3 patents, Goebel has made strides in developing therapeutic compositions aimed at treating brain injuries.

Latest Patents

Among his latest patents are "Cyclic-GluR6 analogs, methods of treatment and use," which describes a composition that acts as a reversible inhibitor of neuron-specific PDZ domains. Another important patent is "Neuroprotective composition and method of use," which details a therapeutic composition for treating brain injury. This composition includes a polyarginine peptide consisting of 5 to 9 arginines and one or more terminal cysteines. The method emphasizes administering the composition in therapeutically effective dosages either prophylactically or as soon as possible post-injury to treat neuronal injury.

Career Highlights

Goebel has had a distinguished career, working with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Brown University. His work in these institutions has contributed to advancements in medical research and treatment methodologies.

Collaborations

Throughout his career, Goebel has collaborated with esteemed colleagues, including John Marshall and Mark R Spaller. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Dennis J Goebel's work exemplifies the impact of innovative thinking in the medical field. His patents and career achievements highlight his commitment to advancing neuroprotective therapies, ultimately benefiting those affected by brain injuries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…